Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study

OBJECTIVE: To compare effectiveness and safety of warfarin and the direct oral anticoagulants (DOAC) dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation in routine care. METHODS: From nationwide registries, we identified treatment-naïve patients initiating warfarin, dabigatran,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kjerpeseth, Lars J., Selmer, Randi, Ariansen, Inger, Karlstad, Øystein, Ellekjær, Hanne, Skovlund, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709911/
https://www.ncbi.nlm.nih.gov/pubmed/31449560
http://dx.doi.org/10.1371/journal.pone.0221500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709911/
https://www.ncbi.nlm.nih.gov/pubmed/31449560
http://dx.doi.org/10.1371/journal.pone.0221500

Ejemplares similares